Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Jiamao Lin"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundSquamous cell carcinoma (SCC) is one of the most common subtypes of non-small cell lung cancer, but its treatment options remain limited. Epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors (TKIs) have limited efficacy in t
Externí odkaz:
https://doaj.org/article/4ab56468788d499099f5c2838a70bb98
Publikováno v:
The Astrophysical Journal, Vol 968, Iss 1, p 22 (2024)
Research has shown that many young and intermediate-age clusters (younger than ∼2 Gyr) have extended main sequences and extended main-sequence turnoffs (eMSTOs), which cannot be adequately described by a single isochrone. The reason for the extende
Externí odkaz:
https://doaj.org/article/4430eb6c8a6e4851b995a7bfb26cd638
Autor:
Chenyue Zhang, Kai Wang, Wenjie Liu, Jiamao Lin, Zhenxiang Li, Hui Wang, Chenglong Zhao, Yanhua Chen, Shuangxiu Wu, Airong Yang, Jiayan Wu, Haiyong Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAs a rare subtype of primary lung adenocarcinoma (LUAD), mucinous pulmonary adenocarcinoma (MPA) was considered a distinctive entity with unfavorable outcomes. Therefore, there is a great need for a better understanding of the genomic and i
Externí odkaz:
https://doaj.org/article/70d3a516453b4c188270fe1dc87d0fa0
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundAt present, there is a lack of studies focusing on the survival prediction of patients with non-small cell lung cancer (NSCLC) receiving atezolizumab in light of gene mutation characteristic.MethodsPatients with NSCLC receiving atezolizumab
Externí odkaz:
https://doaj.org/article/23d858157af4498bb1f4002174830bd6
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background This study aimed to evaluate the feasibility and prognostic accuracy of incorporating the number of positive lymph nodes (PLN) into the TNM staging system for non-small cell lung cancer (NSCLC) patients. Methods We screened a tota
Externí odkaz:
https://doaj.org/article/c8be6f0a839e4e8590230853b60a2aa8
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 1, Pp 290-300 (2018)
Background/Aims: An increasing number of studies have suggested that circular RNAs (circRNAs) have vital roles in carcinogenesis and tumor progression. However, the function of circRNAs in hepatocellular carcinoma (HCC) remains poorly characterized.
Externí odkaz:
https://doaj.org/article/b1a6d163e43d44a5a664a5d0565e3659
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Estrogen receptor β (ERβ) can regulate cellular signaling through non-genomic mechanisms, potentially promoting resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). However, the mechanisms underlying the ERβ-med
Externí odkaz:
https://doaj.org/article/e18d08f8782c402db14a1105e71bb655
Autor:
Chenxing Zhang, PhD, Chenyue Zhang, PhD, Jiamao Lin, PhD, Zhenxiang Li, PhD, Haiyong Wang, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 1, Iss 1, Pp 100006- (2020)
Introduction: There is no consensus on whether immune checkpoint inhibitors (ICIs) would offer comparable benefit in mutant-BRAF NSCLC. We, therefore, conducted a study to ascertain the role of ICIs in mutant-BRAF NSCLC. Methods: Records of 4178 pati
Externí odkaz:
https://doaj.org/article/59422539b48c4e3f9bdeee7be3dd75c3
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Surgery is commonly recommended for patients with stage I small-cell lung cancer (SCLC), whereas chemotherapy and radiotherapy are considered the standard treatment for patients with stage III SCLC. However, recent studies have suggested that a small
Externí odkaz:
https://doaj.org/article/6374fb4a2836477c83bcd52faeefdc7e
Publikováno v:
Future Oncology. 18:3031-3041
Aim: To explore the association between TP53 mutation and atezolizumab in non-small-cell lung cancer (NSCLC) patients. Materials & methods: Patients with NSCLC from the POPLAR and OAK studies were included. Kaplan–Meier analysis was performed to de